Working… Menu
Trial record 1 of 1 for:    1774 | Eosinophilic Esophagitis
Previous Study | Return to List | Next Study

Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03633617
Recruitment Status : Active, not recruiting
First Posted : August 16, 2018
Last Update Posted : April 14, 2021
Information provided by (Responsible Party):
Regeneron Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 16, 2021
Estimated Study Completion Date : July 12, 2022